Kinga Filipek

Kinga Filipek

Auto-generated profile, based on publicly available information

Kinga Filipek

Miedzyleski Specialist Hospital in Warsaw, Poland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
FCFilip Czyżewski
Filip Czyżewski
ABAlicja Baranowska
Alicja Baranowska
KBKatarzyna Baranowska
Katarzyna Baranowska
KFKinga Filipek
Kinga Filipek
JKJakub Kawka
Jakub Kawka
NZNatalia Zalewska
Natalia Zalewska
Introduction: Metabolic syndrome is a wide-spread disease that affects even 30% of Polish population. The mentioned syndrome consists of: glucose intolerance, obesity, dyslipidaemia and high blood pressure. Change of lifestyle, particularly diet, is a crucial part of treatment of those issues. Artificial sweeteners are low-calorie or non-nutritive substances that are made for lowering sugar amounts in sweetened beverages. The use of artificial sweeteners rises among those, who want to lower their weight. Artificial sweeteners are well known substances, but their impact on health is still a matter of studies. We want to summarize the current knowledge about their impact on metabolic syndrome and its elements. Objectives: The review and presentation of the current state of knowledge on impact of artificial sweeteners on metabolic syndrome and its components. Material and methods: Review of the studies available on open access sources at PubMed, Google Scholar, National Library of Medicine and Coachrane. Conclusions: Currently there is no evidence of positive impact of artificial sweeteners on the metabolic syndrome. Moreover, new studies prove a negative impact of those substances at obesity, glucose intolerance, dyslipidaemia and blood pressure. However there is a need of further studies about physiology of gut microbiota and current subject to strengthen current depth of evidence.

24 November 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
WMWaldemar Mrugała
Waldemar Mrugała
BSBartosz Skierkowski
Bartosz Skierkowski
SMSebastian Mrugała
Sebastian Mrugała
MMMichał Muciek
Michał Muciek
JKJakub Kawka
Jakub Kawka
NZNatalia Zalewska
Natalia Zalewska
Introduction and objective Obesity, characterized by excessive fat accumulation, poses significant health risks. The WHO classifies overweight as a BMI of 25 to <30 kg/m² and obesity as a BMI of ≥30 kg/m², divided into three classes. This study examines the relationship between obesity and bone health, focusing on osteoarthritis (OA), rheumatoid arthritis (RA), and fracture risks. Review methods A review of epidemiological and clinical studies was conducted, including WHO statistics, U.S. obesity trends, and recent findings on the mechanisms linking obesity with bone health and joint diseases. Studies were selected for their relevance to understanding obesity's impact on skeletal health. Abbreviated description of the state of knowledge Obesity is influenced by sociodemographic, behavioral, and genetic factors. While excess weight was once considered beneficial for bones due to increased mechanical loading, recent research shows its harmful effects. Obesity is linked to chronic inflammation, altered adipokine levels, and higher risk of atypical fractures. In OA, obesity accelerates joint degeneration through mechanical and metabolic pathways. In RA, obesity is associated with increased disease activity and cardiovascular complications. Summary Obesity significantly affects bone and joint health, increasing the risk of OA, RA, and fractures. The paradox of obesity providing mechanical benefits while causing metabolic and inflammatory issues is crucial. Understanding these mechanisms is vital for developing effective prevention and management strategies for obesity-related skeletal diseases. Further research is essential to clarify the complex interactions between adipose tissue and bone health, aiming to improve outcomes for obese individuals.

17 April 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
JKJakub Kawka
Jakub Kawka
ABAlicja Baranowska
Alicja Baranowska
KBKatarzyna Baranowska
Katarzyna Baranowska
FCFilip Czyżewski
Filip Czyżewski
KFKinga Filipek
Kinga Filipek
NZNatalia Zalewska
Natalia Zalewska
Glaucoma is a group of progressive neuropathies of the optic nerve leading to the destructionof retinal ganglion cells and their axons. It is the leading cause of irreversible blindnessworldwide, affecting over 70 million people residing in various geographical regions. Thisdisease ranks second among the causes of blindness in patients. Up to 40% of them lose theirvision within the first year of diagnosis.(1) The most common type of glaucoma affectingophthalmic patients is open-angle glaucoma, in which the iridocorneal angle is notpathologically altered, but there is an elevation of intraocular pressure due to abnormal fluidflow within the eye. The main cause of this disease is obstruction of aqueous humor outflowfrom the eye and its excessive production. Although the exact mechanism of glaucoma is notfully understood yet, several risk factors have been identified, including high intraocularpressure (IOP), age, and genetics. Materials and Methods: Review and summary of research studies available in open-sourceformat on Google Scholar, PubMed.Conclusions: There is ample evidence confirming the impact of food products on the risk ofdeveloping glaucoma or exacerbating its symptoms. However, further research is necessary todetermine the extent of their interference with this disease entity.

16 November 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
KFKinga Filipek
Kinga Filipek
NZNatalia Zalewska
Natalia Zalewska
BSBartosz Skiekowski
Bartosz Skiekowski
WMWaldemar Mugała
Waldemar Mugała
SMSebastian Mrugała
Sebastian Mrugała
ABAlicja Baranowska
Alicja Baranowska
Introduction and purpose: Adrenal disorders cover a spectrum of conditions, including adrenal insufficiency, Cushing's syndrome and others. Each disorder has its own implications for pregnancy and requires an individualised approach. This review aims to provide a comprehensive overview of adrenal disorders during pregnancy, such as endogenous Cushing's syndrome, adrenal insufficiency, primary aldosteronism, and pheochromocytoma. Brief description of the state of knowledge: During pregnancy, a number of adaptive processes take place in a woman's body including changes in the endocrine system. Given all these changes, adrenal diseases pose both diagnostic and therapeutic challenges. The symptoms of adrenal diseases often overlap with those observed during physiological pregnancy. Adrenal disorders during pregnancy if unrecognised or treated inadequately, can lead to negative consequences for the mother and foetus, indicating the importance of awareness of these conditions among physicians. Conclusions: Treating and diagnosing adrenal diseases during pregnancy is a major challenge for doctors. It is crucial to diagnose adrenal diseases in pregnant women as early as possible, and to meticulously plan pregnancies for women diagnosed before conception to prevent the negative consequences of untreated adrenal disorders. Optimal control of treatment before conception should be sought. Access to specialised centres with multidisciplinary teams experienced in treating these conditions is crucial for optimal maternal and foetal care.

31 August 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
BSBartosz Skierkowski
Bartosz Skierkowski
ABAlicja Baranowska
Alicja Baranowska
KBKatarzyna Baranowska
Katarzyna Baranowska
FCFilip Czyżewski
Filip Czyżewski
KFKinga Filipek
Kinga Filipek
NZNatalia Zalewska
Natalia Zalewska
Introduction: Pheochromocytomas are rare tumors originating from the adrenal medulla, which can occur sporadically or as part of hereditary syndromes. Many patients with chromaffin tumors harbor genetic mutations, typically inherited in an autosomal dominant manner, hence genetic testing is recommended for all patients. Symptoms can result from both excessive catecholamine production and the mass effect of the tumor. Diagnosis is confirmed by elevated levels of metanephrines or normetanephrines in the plasma or urine. Radiological imaging aids in tumor localization and assessment of potential local invasion or metastasis. Preoperative preparation of all patients involves the use of α-receptor blockers and/or other medications to control arterial hypertension, arrhythmias, and fluid volume. Surgery remains the treatment of choice, with lifelong follow-up recommended.Objective:The review article aims to provide an overview of chromaffin tumor pathology, their etiology, discuss diagnostic possibilities, and indicate therapeutic options for patients.Materials and Methods:A summary of reports available in medical publications and scientific studies found in databases such as PubMed, CrossRef, Google Scholar, as well as relevant textbooks.Results:Chromaffin tumors are rare but dangerous for patients; adequate pharmacological preparation for surgery, which is usually necessary, is extremely important.Conclusions:The main role is to establish the correct diagnosis, or even suggest and conduct diagnostic tests towards a chromaffin tumor. Patient management involves controlling blood pressure, appropriate premedication, and surgical intervention. After such treatment, patients require continuous monitoring to detect any potential disease recurrence.

21 December 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
SMSebastian Mrugała
Sebastian Mrugała
WMWaldemar Mrugała
Waldemar Mrugała
JKJakub Kawka
Jakub Kawka
ABAlicja Baranowska
Alicja Baranowska
KBKatarzyna Baranowska
Katarzyna Baranowska
NZNatalia Zalewska
Natalia Zalewska
Age-related macular degeneration (AMD), one of the leading causes of vision loss among the elderly, poses a significant global health issue. This is a retinal condition that causes the loss of central vision. The demographic shift towards an aging population contributes to the increasing number of individuals affected by this condition, presenting a challenge to the medical and scientific community in developing effective prevention and treatment methods. In recent years, considerable attention has been given to the role of a proper diet and the supplementation of vitamins and antioxidants in inhibiting the progression of AMD.